IOVA: Iovance Biotherapeutics, Inc. Stock

by  •  • Comments Off on IOVA: Iovance Biotherapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,006.58
Enterprise Value ($M) 891.89
Book Value ($M) 710.40
Book Value / Share 2.17
Price / Book 1.42
NCAV ($M) 257.00
NCAV / Share 0.78
Price / NCAV 3.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.48
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.55

Liquidity (mrq)
Quick Ratio 3.31
Current Ratio 3.74

Balance Sheet (mrq) ($M)
Current Assets 457.02
Assets 910.43
Liabilities 200.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 164.07
Operating Income -395.28
Net Income -372.18
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -352.98
Cash from Investing -96.41
Cash from Financing 390.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Perceptive Advisors Llc 7.30 -16.93
10-18 13G/A State Street Corp 4.40 -19.62
2024-03-19 13D/A Quogue Capital LLC 11.60 20.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K
2024-11-07 10-Q +- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q +- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q +- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 2,311,280 9,072,228 25.48
2025-04-16 1,788,395 7,521,444 23.78
2025-04-15 1,856,229 5,976,623 31.06
2025-04-14 2,641,041 8,829,915 29.91

(click for more detail)

Similar Companies
HROW – Harrow, Inc. IKNA – Ikena Oncology, Inc.
IMRX – Immuneering Corporation IRON – Disc Medicine, Inc.
ITOS – iTeos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io